Securities Code: 002118
Securities Abbreviation: *ST Zixin
Announcement Number: 2023-91
Jilin Zixin Pharmaceutical Co., Ltd. and all members of the board of directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
Special Reminder: Jilin Zixin Pharmaceutical Co., Ltd. is currently under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws. If the company is found to have significant violations that lead to mandatory delisting, its stock may be terminated from listing. Investors are advised to be cautious of investment risks.